ONCOSEC MED INC - COM NEW (ONCS)

CUSIP: 68234L207

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
4,482,667
Share change
+2,526,495
Total reported value
$7,286,000
Price per share
$1.63
Number of holders
29
Value change
+$4,179,836
Number of buys
20
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q4 2017

As of 31 Dec 2017, ONCOSEC MED INC - COM NEW (ONCS) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,482,667 shares. The largest 10 holders included Point72 Asset Management, L.P., Vanguard Group Inc, Crawford Lake Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, SABBY MANAGEMENT, LLC, J. Goldman & Co LP, PRICE T ROWE ASSOCIATES INC /MD/, Zurcher Kantonalbank (Zurich Cantonalbank), and MYDA Advisors LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.